|
HS Code |
263449 |
| Cas Number | 826-36-8 |
| Molecular Formula | C11H14O4 |
| Molecular Weight | 210.23 |
| Iupac Name | 1-(2,3,4-trimethoxyphenyl)ethan-1-one |
| Appearance | White to off-white crystalline powder |
| Melting Point | 62-64°C |
| Boiling Point | 337.6°C at 760 mmHg |
| Density | 1.18 g/cm³ |
| Solubility | Soluble in organic solvents (e.g., ethanol, ether) |
| Smiles | COC1=C(C=CC(=C1OC)C(=O)C)OC |
| Refractive Index | 1.535 |
| Pubchem Cid | 148744 |
| Flash Point | 156.8°C |
As an accredited 2',3',4'-Trimethoxyacetophenone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 2',3',4'-Trimethoxyacetophenone, 25g, is supplied in a sealed amber glass bottle with a secure screw cap and safety label. |
| Shipping | **Shipping Description:** 2',3',4'-Trimethoxyacetophenone is shipped in secure, airtight containers to protect from moisture and contamination. Packaging complies with chemical safety regulations. The product is transported as a non-hazardous material, labeled for laboratory use only. Relevant documentation, including Safety Data Sheets (SDS), accompanies each shipment to ensure safe handling during transit. |
| Storage | 2',3',4'-Trimethoxyacetophenone should be stored in a cool, dry, and well-ventilated area, away from sources of ignition or heat. Keep the container tightly closed and protect it from light and moisture. Store separately from incompatible materials such as strong oxidizers. Use appropriate chemical-resistant containers and ensure proper labeling to prevent accidental misuse or contamination. |
Applications of 2',3',4'-Trimethoxyacetophenone in Industrial Manufacturing2',3',4'-Trimethoxyacetophenone serves as a specialty intermediate in multiple value chains that require precise substitution patterns on aromatic compounds. Our direct manufacturing supply supports diverse downstream chemical synthesis routes for regulated and high-value end-applications. 1. Pharmaceutical Intermediate SynthesisAPI producers use 2',3',4'-Trimethoxyacetophenone to construct complex molecular scaffolds in the synthesis of selective serotonin receptor modulators and other CNS-active compounds. The methoxy-acetophenone core enables regioselective alkylation and amide formation during early-stage production, where in-process analytical controls maintain batch consistency for downstream active pharmaceutical ingredients. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient ManufacturingProducers of advanced crop protection agents utilize the raw material for the synthesis of methoxy-substituted aromatic building blocks required in selective herbicides and fungicides. Its reactivity profile enables controlled Friedel–Crafts acylation and aromatic nucleophilic substitution, supporting synthesis steps under stringent regulatory oversight. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fragrance and Flavor Additive PrecursorIndustrial fragrance and flavor compound manufacturers rely on this material for introducing precise methoxy patterns in benzene derivatives. Its acetophenone backbone supports ortho-directed synthesis of aromatic aldehydes and ketones used in perfumery and non-food flavors, where batch traceability and purity are mandatory for regulatory acceptance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Polymer Modification and CrosslinkingPerformance polymer manufacturers employ 2',3',4'-Trimethoxyacetophenone to introduce electron-rich aromatic substituents into specialty resins, especially for UV-cured systems and high-durability coatings. The compound enters polymer backbones through controlled copolymerization, enabling specific mechanical and optical properties in the final resin matrix. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2',3',4'-Trimethoxyacetophenone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working directly with 2',3',4'-Trimethoxyacetophenone, or 2,3,4-TMAP, changes the way one sees a compound. Day after day, we measure, stir, observe, and refine processes around these colorless crystals. As a chemical manufacturer, most feedback doesn’t come from spreadsheets or market forecasts. We see it through yield numbers, purity analysis, and the response of our customers’ technical teams who depend on our consistent supply to keep complex syntheses on track.
Chemists know its IUPAC name, but in the plant we call it something we can shout across a warehouse floor. With its structure—three methoxy groups flanking the acetophenone core—2,3,4-TMAP brings more than just another entry in a catalog. The methoxy pattern gives it a special spot among aromatic ketones. It’s often routed into the production chain instead of its cousins, like 2',4',5'-trimethoxyacetophenone or 3',4',5'-trimethoxyacetophenone, because it falls right into niche synthetic streams in the agrochemical, pharmaceutical, and dye intermediate sectors.
The defining feature is its handing of electron density—three methoxy groups at positions 2, 3, and 4 change how this building block reacts. Certain condensed ring systems need this core for optimal reactions, which is why specialty manufacturers request it by model or batch lot, not just as another aromatic compound. This requests a certain respect for the breakdown of benzene derivatives; one extra oxygen, a shift of a methyl, and suddenly, everything about the process changes: from crystallization to final filtration.
We produce 2,3,4-TMAP using a methylation protocol built for scalability. Years of manufacturing have taught us that even a quarter-degree’s variation in process temperature impacts final purity. In practice, customers ask about Melting Point, HPLC purity, and actual GC/MS traces, not just the “assay >99%” found in many marketing blurbs. Experienced buyers want real batch records. They know that during downstream synthesis, even minor impurities in the methoxy-acetophenone family can result in isolation headaches or colored byproducts.
From handling experience, 2,3,4-TMAP typically presents as faintly off-white to cream-colored crystals—a sign that the last filtration step and drying worked as intended. If it’s too white, some suspect overwashed product or incomplete drying. If even a slight yellow tinge shows under warehouse lighting, our QC staff gets involved. Water content below 0.2% by Karl Fischer titration is our in-house practice, not just a certificate claim, because those who buy from us tracked trace water to failed reactions.
We pack product in 25-kilogram fiber drums with polyethylene liners. Over the years, we discovered that smaller break-pack bags surprisingly allow more ambient moisture ingress, so bulk is always better for lab-scale and pilot quantities. Full-size formats minimize transfer losses and contamination risk per weigh-in cycle. Each drum ships after a double QC release—one physical, one analytical—so what reaches customers has already matched our in-house and client-side purity checks.
Customers rarely use this compound as a finished good. Often, 2,3,4-TMAP sits just one or two steps from pharmacologically relevant entities or color-fast dye backbones. Even so, the way it enters a synthetic protocol matters a great deal. Specialists in pharmaceutical intermediates insist on certain polymorph ranges and impurity fingerprints because many downstream reactions are unforgiving; yields drop, color morphs, and product isolation grows unpredictable once a feedstock drifts out of spec.
Over time, we noticed that customers focused on downstream methylation or demethylation cycles source directly from us, rather than gambling on multi-layered traders, because trace contaminants—often under 0.5%—change reaction rates in Paal-Knorr or Friedel-Crafts extensions. A universal feedback theme from skilled process chemists: “Raw material consistency saves time in scale-up.”
2,3,4-TMAP is also selected for specific oxidative and nucleophilic substitution reactions involving aromatic systems. Unlike the more symmetrical 3',4',5'- trimethoxyacetophenone, our product delivers a particular substitution pattern that helps customers create regioselective intermediates for drugs and colorants. This isn’t random. Over dozens of pilot projects, we’ve seen teams re-tool entire routes around availability and purity, specifically because the compound’s three methoxy groups activate or block ring positions for downstream functionalization with high selectivity.
Some buyers ask about non-traditional applications, such as photochromic dyes or advanced materials. In these areas, process consistency becomes especially important. Non-standard uses push the need for low metal content and ultralow organic impurities. Over the years, we’ve responded by running additional purification to address special requests, sometimes producing highly refined batches via preparative HPLC for research scale. This wouldn’t happen if the compound didn’t show versatility with reliable yield response in other chemists' hands.
Many who order methoxyacetophenones for the first time wonder about interchangeability with similar compounds. From where we sit, the answer is almost always negative. Even a single methoxy positional change leads to altered reactivity. For example, the 2',4',5'- version sticks on substrates differently; this can double or halve yields in key condensation reactions. The 3',4',5'- version, with its symmetric placement, encourages different ring activation, an effect well documented in academic literature and obvious in plant-scale operations.
We’ve witnessed the costs customers pay for small oversights: batches lost to low conversion, columns clogged with byproducts, or off-reactivity causing darkened residues instead of clean product isolation. The difference also surfaces during purification. The melting range for 2,3,4-TMAP (usually around 62-64 °C on fresh production) solves a persistent problem seen with the 3',4',5'- compound—to avoid co-crystallization and achieve reliable, scalable filtration. Lab techs bring this up less in documentation and more during troubleshooting calls, when timelines shrink and budgets face pressure.
Supply chain transparency also differs. Some analogs are imported via long chains of intermediaries, making traceability a challenge. We’ve made it a policy to work with partners who value local production and full batch traceability. This reduces the risk of mix-ups or contamination events, both of which can disrupt multi-million-dollar manufacturing campaigns on short notice.
Real-world feedback tells us that “purity” doesn’t end with a headline HPLC or GC figure. Trace isomer formation occurs if upstream methylation or acetylation steps run too long or under the wrong catalyst. Over many campaigns, we found that batch reproducibility over dozens of runs matters as much as single-run numbers. Analytical teams use NMR (1H and 13C) to check for indication of para/ortho impurity. By running longer columns and extensive solvent rinses, we aim for spectra that match reference standards, not just pass visual inspection or minimum area percent.
Separating trace colored impurities often means double-stage crystallization—an extra step compared to lesser-used analogs. Without it, certain pharmaceutically focused customers return product, and entire campaigns pause for repeat purification. This feedback loop shaped our standard operating procedures: purity isn’t only on paper. It shows in smoother reactions, higher downstream yields, and fewer call-backs for technical support from process teams.
We built our batch release system through trial and error. Product isn’t just checked for melting range and color. Each run faces a battery of analytics: HPLC, GC/MS, NMR, residual solvent analysis, Karl Fischer, heavy metal checks. Early customers forced us to automate trace reporting for easy data transfer, including COA auto-generation and archiving. Once, a single failed detection led to trace iron contamination; that cost a major customer a week of downtime and taught us to run both ICP-MS and wet chemical tests for metals, even at microgram levels.
Once a technical team flagged a slight shift in melting range during a pilot scale-up. We found it traced not to reagent quality, but to small pressure fluctuations in our drying oven. Nobody learns such nuances from the data sheets alone; only after repeated experience with hands-on process work do these insights accumulate.
Our most successful partnerships are with organizations that understand process nuance and require reliability over long development cycles. They test product batches not only at goods-in but also post-reaction, tracking every metric from color drift to yield. We often support custom runs—by varying crystallization temperature, reprocessing lots, or shifting particle size distributions on demand. This is only feasible with a direct line back to the manufacturing plant, not through opaque distributor chains.
Industries sourcing for API development, intermediates for agrochemicals, or pilot projects in dye manufacturing have all reported lower troubleshooting rates when ordering directly from us. By keeping technical and production staff on the same page, we shorten feedback cycles and fix issues before they become delays in downstream syntheses.
One lesson stands out: traceability keeps processes resilient in the face of regulatory checks or batch recalls. We developed a container tracking protocol to enable full backward and forward lot trace without third-party bottlenecks. This system means any query—regarding solvent residues, route details, or compliance with end-market testing—gets answered using our own run control logs, maintenance records, and chromatographic archives. When customers run into regulatory or QC questions, they value quick, detailed responses.
Unlike many commercial intermediates, 2,3,4-TMAP rarely enters the market as a byproduct. Most lots result from direct, purpose-driven synthesis rather than afterthought isolation. This focus allows for better documentation, records management, and continuous improvement cycles on the plant floor. More than once, auditors have commented on the advantage this brings in reducing the risk of off-specification product release.
Routine interaction with packaging teams taught us what technical data sheets ignore: static buildup, container permeability, and re-seal quality influence real-world performance. We use high-barrier fiber drums with polyliners—not for marketing appeal, but because, over hundreds of shipments, moisture ingress or loss through less robust materials caused headaches for both us and buyers. Squeezing savings in packaging invites more product returns than it prevents.
In the plant, we protect against caking or static charging by managing humidity and storage temperature, both before and after QC signoff. Shipment teams rotate stock based on FIFO rules, tuned for the compound’s actual shelf stability. If a shipment date aligns with the local monsoon season, we double-layer outer wrapping on exports. Details like these, gathered from real usage and customer calls, drive our best practice protocols.
As a chemical producer, we don’t just ship to a specification; we take responsibility for ensuring safe handling in warehouses and downstream plants. In production, our teams always monitor exhaust and solvent capture, as methoxy compounds volatilize readily at scale. Years of incident logs have shown that leak detection and containment, not just MSDS compliance, lead to safer operations. In shipping, we note that product handled with insufficient PPE or in open dives leads to operator exposure; most issues in storage, such as yellowing or caking, come from inadequate ventilation or unsuitable packaging.
Waste streams receive careful tracking. Recovered solvents from crystallization and washing cycles get reconsolidated and treated. Customers occasionally ask about the environmental profile of our process; we provide full documentation of emissions, including efforts to reduce residual waste through targeted process improvements.
We’ve lived through supply fluctuations caused by shifting regulations—such as the restriction of precursor chemicals or changes in documentation required for import/export by different countries. Back in 2018, an upstream change in methylating agent regulation required us to overhaul part of our process, leading to a costly multi-month retrofit and additional downtime. Today, we actively follow regulatory trends, adjusting documentation and compliance so that our customers don’t experience late surprises with customs or local authorities.
Many manufacturers only discover documentation gaps during regulatory site audits, but we favor a preemptive strategy—auditing our own process and technical documentation yearly, even when customers do not request it. This reduces reaction times to changing rules and ensures long-term supply agreements remain stable.
Manufacturing 2,3,4-TMAP at scale opens up new process approaches, especially as green chemistry options become more viable. Years ago, we transitioned away from older, high-waste methylation steps to more selective protocols, which cut down on both raw material bills and waste by roughly 15%. Current pilot projects focus on continuous flow techniques, yielding smaller process footprints and higher throughput. Our own experience suggests that incremental investments here pay off not through marketing claims, but through actual, measured reductions in downtime, waste, and off-batch rework.
Process innovation doesn’t just sit on the plant manager’s desk. Operators, analysts, and maintenance staff often spot ideas for improvement when they see small inefficiencies—such as cleaning cycles that could be shortened or monitoring points that flag purity drift hours before finished product tests do. Many of our best changes started with feedback from the shop floor, not top-down directives.
Most improvements in our process and final product specification come from customers who take time to share failed syntheses, poor yields, or subtle performance differences with our technical team. Open communication helps; three-way troubleshooting, involving our chemists, the buyer’s process team, and sometimes even equipment vendors, helps find exact points of intervention. We share unfiltered batch data for every shipment, allowing comparison with historical records. This transparency opens doors to mutual problem-solving and cements long-term relationships based on shared success rather than transactional one-offs.
We’ve lent technical staff to assist with setting up customer pilot batches or solving tough impurity profiles, providing not just product but practical troubleshooting based on real-world process knowledge. These collaborations highlight the critical nature of compound consistency and purity; a well-established, repeatable production protocol benefits everyone in the chain by reducing troubleshooting time and improving outcomes.
Though 2',3',4'-Trimethoxyacetophenone manufacturing has matured, challenges remain on both technology and market sides. Increased demand from pharmaceutical trial expansion has created periods of tight supply, while continual tightening of environmental and safety expectations keeps pushing our facility’s process control and documentation to new standards. We’ve seen that constant review and incremental change—sometimes as small as a new dry room protocol or upgraded analytical method—substantially smooth production hiccups.
Raw material volatility and logistics complexities, especially with global disruptions, force us to keep inventory higher than before and maintain alternate sourcing for critical upstream reagents. We also run more frequent mock recall drills, so if a quality or regulatory issue ever emerged, real-world experience would guide our response, not just procedures on paper.
Our path manufacturing 2',3',4'-Trimethoxyacetophenone stretches years and runs through the hands of every technician, analyst, and operations manager on site. Each improvement—be it in process development, analytical rigor, packaging, or customer transparency—emerged from cumulative trial, error, and collaboration. Intermediates might seem like background players to outsiders, but small shifts in their purity, trace composition, or supply chain stability create ripple effects in every product further down the value stream.
We think of 2',3',4'-Trimethoxyacetophenone not as a commodity, but as a precision-built tool for demanding chemists, who value experience, transparency, and real-world partnership. Reliable manufacturing isn’t just about ticking boxes; it is about doing the work, tracking what matters, and improving every handoff from plant to end user. Anyone with questions about this compound’s nuance, handling, or current production status can always find an informed answer grounded in daily production reality—not marketing spin or distant supply chains.